Time for a systematic approach to the treatment of hepatitis C virus infection in injection drug users

By Conway Brian   Grebely Jason   Duncan Fiona  

Future Virology, Vol. 1, Iss. 2, 2006-03 ,pp. : 139-141

Future Medicine

Access to resources Recommend Favorite

HIV Infection Risk among Injection Drug Users in a Methadone Maintenance Treatment Program, Taipei, Taiwan 2007–2010

By Yen Yung-Feng   Rodwell Timothy C.   Yen Muh-Yong   Hsu Yun-Hsia   Chuang Peing   Li Lan-Huei   Su Lien-Wen   Yang Yi-Hong   Jiang Xiao-Ru   Fang Yung-Chun   Garfein Richard S.  

The American Journal of Drug and Alcohol Abuse, Vol. 38, Iss. 6, 2012-11 ,pp. : 544-550

Informa Healthcare

Access to resources Recommend Favorite

Adjuvant Treatment in Non-Small Cell Lung Cancer: Where Are We Now?

By Juergens Rosalyn A.   Brahmer Julie R.  

Journal of the National Comprehensive Cancer Network (JNCCN), Vol. 4, Iss. 6, 2006-07 ,pp. : 595-600

Cambridge Scholars Publishing in association with GSE Research

Access to resources Recommend Favorite

Bivalirudin or Heparin Treatment During Transcatheter Valve Interventions: Where are we Now?

By  

Current Pharmaceutical Design, Vol. 22, Iss. 13, 2016-04 ,pp. : 1911-1917

Bentham Science Publishers

Access to resources Recommend Favorite

Examining Drug Treatment Entry Patterns Among Young Injection Drug Users

By Shin Sunny Hyucksun   Lundgren Lena   Chassler Deborah  

The American Journal of Drug and Alcohol Abuse, Vol. 33, Iss. 2, 2007-03 ,pp. : 217-225

Informa Healthcare

Access to resources Recommend Favorite